Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/AKESO-INC-111325370/noticia/Akeso-Inc-Publica-en-ASH-2023-los-resultados-del-anticuerpo-CD47-ligufalimab-en-combinaci-n-con-a-45585182/?utm_source=whatsapp&utm_medium=social&utm_campaign=share